Skip to Content
Symphonies
Exothermic R&D Squeeze
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

A 3-slice, tactical stock/ETF mix. If BE, QS, or IONQ had a strong day, buy them (BE pairs with a short energy fund). Otherwise, rotate into recent winners in real estate/homebuilders, Asian tech/semis, and biotech. Includes some 2x/3x ETFs.
NutHow it works
The portfolio is split into 3 slices. Each slice first checks a specific high‑R&D stock: Bloom Energy (BE), QuantumScape (QS), or IonQ (IONQ). If that stock was up today, buy it (the BE slice also pairs with an energy bear fund). If not, buy the best recent performers in that slice’s group (real estate/homebuilders; Asian tech/semis; biotech). steadier picks get bigger weights. Uses some 2x/3x funds, so swings can be large.
CheckmarkValue prop
Out-of-sample data shows this strategy underperforms SPY (negative alpha, higher drawdowns). It's best used as a small satellite sleeve for risk-tolerant investors seeking tech/biotech exposure and diversification, not a core SPX replacement.
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
0.251.210.240.49
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
60.91%21.79%-2.54%-4.14%1.33
Exothermic R&D Squeeze
181.34%53.53%-18.46%-13.96%1.3
Initial Investment
$10,000.00
Final Value
$28,133.81
Regulatory Fees
$230.75
Total Slippage
$1,309.95
Invest in this strategy
OOS Start Date
Jan 13, 2026
Trading Setting
Threshold 0.25%
Type
Stocks
Category
Equities, tactical rotation, tech/semis, biotech/genomics, real estate/homebuilders, asia (korea/taiwan), leveraged etfs
Tickers in this symphonyThis symphony trades 26 assets in total
Ticker
Type
ALNY
Alnylam Pharmaceuticals, Inc.
Stocks
ARKG
ARK Genomic Revolution ETF
Stocks
BALI
iShares U.S. Large Cap Premium Income Active ETF
Stocks
BE
Bloom Energy Corporation
Stocks
BEAM
Beam Therapeutics Inc. Common Stock
Stocks
BSX
Boston Scientific Corp.
Stocks
CRSP
CRISPR Therapeutics AG
Stocks
ERY
Direxion Daily Energy Bear 2X ETF
Stocks
EWT
iShares MSCI Taiwan ETF
Stocks
EWY
iShares MSCI South Korea ETF
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"Exothermic R&D Squeeze" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"Exothermic R&D Squeeze" is currently allocated toSMH, PLD, LABUandTSM. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "Exothermic R&D Squeeze" has returned -54.05%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "Exothermic R&D Squeeze" is 28.75%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "Exothermic R&D Squeeze", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, and options.